Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

A RCT of Collagen Scaffold for the Repair of Talus Cartilage Injury

3 november 2026 bijgewerkt door: Beijing Jishuitan Hospital

A Prospective Randomized Controlled Study Of Collagen Scaffold For The Repair Of Talus Cartilage Injury

The goal of this clinical trial is to test whether adding a collagen protein scaffold can improve cartilage repair of talus injury, compared to standard surgery alone. The study will enroll 40 patients (aged 18-55) with talus cartilage damage who haven't responded to conservative treatments.

The main questions it aims to answer are:

  • Does the collagen scaffold help regenerate better-quality cartilage (measured by MRI scans at 3/6 months and 1/2 years)?
  • Do patients experience better pain relief and ankle function after this combined treatment?

Researchers will compare two groups:

  • Experimental group: Receives microfracture surgery + collagen scaffold implant
  • Active Comparator group: Receives microfracture surgery alone

Participants will:

  • Undergo arthroscopic surgery (either procedure)
  • Complete follow-up visits at 1 week, 1 month, 3 months, 6 months, 1 year and 2 years
  • Have MRI scans and functional assessments
  • Report pain levels and daily activity limitations through questionnaires

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Geschat)

40

Fase

  • Fase 3

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Beijing Municipality
      • Beijing, Beijing Municipality, China
        • Beijing Jishuitan Hospital, Capital Medical University

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 55 jaar (Volwassen)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  1. Subjects are between the ages of 18 and 55 (including 18 and 55 years old);
  2. Articular cartilage defect reaches Outerbridge grade III/IV;
  3. The area of cartilage defect in a single site is 1cm²-3cm²;
  4. BMI 18≤BMI≤30;
  5. Clinically diagnosed cartilage defect requiring arthroscopic microfracture;
  6. Have not participated in other clinical trials within 3 months;
  7. Conservative treatment for more than 3 months has not been effective
  8. Subjects fully understand the benefits and risks of this trial, are willing to participate and sign the informed consent form, and are able to cooperate with clinical follow-up

Exclusion Criteria:

  1. Subjects with significant narrowing of the ankle joint space or bony ankylosis (bone bridge formation).
  2. Subjects with severe subchondral bone damage unsuitable for microfracture surgery.
  3. Subjects with severe ankle deformity or systemic bone/joint diseases.
  4. Subjects with allergic predisposition (e.g., porcine protein allergy) or personal/family history of autoimmune diseases.
  5. Subjects who received autologous bone marrow mesenchymal stem cell transplantation or other cartilage regeneration surgery for cartilage defects in the affected ankle within 12 months prior to surgery.
  6. Subjects whose ankle cartilage injury was caused by articular fractures, infections, tumors, or immune-mediated diseases.
  7. Subjects with ankle tumors, rheumatoid arthritis, tuberculosis, suppurative arthritis, or complications affecting joint structure.
  8. Subjects with secondary ankle arthritis accompanied by psoriasis, syphilitic neuropathy, ochronosis, or metabolic bone diseases.
  9. Subjects with frequent use of sedatives, hypnotics, tranquilizers, or other addictive drugs.
  10. Subjects with severe primary cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic system diseases, or psychiatric disorders.
  11. Subjects unable to comply with long-term intensive postoperative rehabilitation.
  12. Female subjects planning pregnancy within 12 months, or currently pregnant or lactating.
  13. Subjects with specific religious beliefs prohibiting porcine-derived products.
  14. Other subjects deemed ineligible by investigators (e.g., inability to evaluate treatment efficacy).

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Verdrievoudigen

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Microfractuur

Microfracture to repair cartilage defect is a minimally invasive procedure that is usually done arthroscopically. The doctor first cleans the damaged cartilage area, and then uses a special microfracture cone to drill vertically in the subchondral bone plate, forming multiple tiny holes, allowing mesenchymal stem cells and growth factors in the bone marrow to overflow, forming a blood clot rich in repair components, and finally stimulating fibrocartilage regeneration to fill the defect area.

Experimenteel: Microfracture + Collagen scaffold

The collagen cartilage scaffold(COLTRIX® CartiRegen) used in this study consist of an injection needle, a syringe, and a collagen gel prefilled in a syringe. The collagen gel contains phosphate buffer and type I collagen which the telopeptides are removed.. After the product is implanted in the body, it forms a degradable three-dimensional scaffold to provide an environment for cells to adhere, proliferate, migrate, differentiate and secrete, thereby promoting cartilage repair. At present, it has been commercially applied to clinical repair of knee cartilage defect.

Microfracture to repair cartilage defect is a minimally invasive procedure that is usually done arthroscopically. The doctor first cleans the damaged cartilage area, and then uses a special microfracture cone to drill vertically in the subchondral bone plate, forming multiple tiny holes, allowing mesenchymal stem cells and growth factors in the bone marrow to overflow, forming a blood clot rich in repair components, and finally stimulating fibrocartilage regeneration to fill the defect area.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
MOCART score
Tijdsspanne: Preoperatively, 3rd and 6th months and 1st and 2nd postoperatively

The MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) scoring system includes multiple dimensions such as the morphology of the repaired tissue, the thickness of the repaired cartilage, the signal intensity of the repaired tissue, the integration of the repaired cartilage with normal cartilage, the bone quality under the repaired cartilage, the accumulation or inflammation of the joint cavity, and the coverage of cartilage defects. Morphology and its integration with the surrounding normal cartilage.

Preoperatively, 3rd and 6th months and 1st and 2nd postoperatively

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Range of motion
Tijdsspanne: Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

The range of motion (ROM), measured in degrees (°) using the neutral-zero method, includes: sagittal plane dorsiflexion (0°-20°) and plantarflexion (0°-50°) at the talocrural joint, and frontal plane/horizontal plane inversion (0°-35°) and eversion (0°-15° to 20°) at the subtalar joint. Anatomically, the neutral reference position is 90° between the foot and leg, with the goniometer axis placed inferior to the lateral malleolus or midpoint of the bimalleolar line, the stationary arm aligned with the fibular/leg axis, and the moving arm aligned with the 5th metatarsal or calcaneus axis. Active and passive ROM should be documented separately, with unilateral findings compared to the contralateral side to assess restriction.

Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.
Visual Analogue Scale(VAS)
Tijdsspanne: Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

A Visual Analogue Scale (VAS) is a straight-line measurement tool where respondents mark their perceived intensity of a symptom-such as pain-along a continuous 0-100 mm continuum.

Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.
Kellgren-Lawrence Grade
Tijdsspanne: Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

The Kellgren-Lawrence (KL) grade is a standardized radiological scoring system (grades 0-4) used to classify the severity of osteoarthritis based on features such as joint space narrowing, osteophytes, and subchondral sclerosis.

Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.
Tegner score
Tijdsspanne: Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

The Tegner score is a clinician-reported scale (0-10) that rates a patient's activity level by linking knee function to the demands of specific sports and occupational activities.

Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.
American Orthopedic Foot and Ankle Society Score (AOFAS)
Tijdsspanne: Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

The AOFAS score is a clinician-based 100-point ankle-foot rating system that evaluates pain, function, and alignment to assess outcomes in foot and ankle disorders.

Preoperatively, 1st week, 1st month, 3rd month, 6th month,1st year and 2nd year postoperatively.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 oktober 2026

Primaire voltooiing (Geschat)

1 augustus 2028

Studie voltooiing (Geschat)

1 augustus 2028

Studieregistratiedata

Eerst ingediend

18 augustus 2025

Eerst ingediend dat voldeed aan de QC-criteria

3 november 2026

Eerst geplaatst (Werkelijk)

5 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

5 november 2026

Laatste update ingediend die voldeed aan QC-criteria

3 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

This study will share the medical history and physical examination, imaging data (X-ray, CT, MRI, etc.) , functional scores, laboratory test results and complications of the two groups of patients with talus cartilage defect.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • MVO

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren